Image (D36fe175 34a6 4627 8778 Da5f98c12391 01)
Bumetanide Injection
Product Images NDC 70748-323
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 70748-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 01 (D36fe175 34a6 4627 8778 Da5f98c12391 02)
This is a description of a medication called Bumetanide Injection, USP for intravenous or intramuscular use. Each mL contains 0.25 mg of bumetanide USP along with sodium chloride, ammonium acetate, edetate disodium, benzyl alcohol, and pH adjusters. The container closure does not contain natural ingredients. The medication is provided in a 4 mL single-dose vial and should be stored between 20°C to 25°C. It should be protected from light and any unused portion should be discarded.*
Image 02 (D36fe175 34a6 4627 8778 Da5f98c12391 03)
This text provides information about a medicine called Bumetanide Injection, USP. Each milliliter contains 0.25 mg of bumetanide USP, 85 mg of sodium chloride, and 4 mg of ammonium acetate as buffers. It also includes disodium edetate, benzyl alcohol as a preservative. It indicates that the container closure does not contain natural rubber latex. The pH is adjusted to 7.8 using sodium hydroxide. The usual dosage information is available in the package insert. It is advised to store the medication at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) to protect it from light.*
Image 03 (D36fe175 34a6 4627 8778 Da5f98c12391 04)
This is a medication description for Bumetanide Injection, USP. Each mL contains bumetanide USP 0.25 mg, sodium chloride 8.5 mg, and ammonium acetate 4 mg as buffers, with edetate disodium 0.1 mg and benzyl alcohol 10 mg as a preservative. The pH is adjusted to 6.8 to 7.8 with sodium hydroxide. The injection is manufactured by Lupin Limited in Nagpur, India, and the usual dosage is 1. It is for intravenous or intramuscular use, and the container closure is not made with natural rubber latex. It should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). This medication is supplied in a 10 mL multiple-dose vial and should be protected from light. For more information, refer to the package insert.*
Image 04 (D36fe175 34a6 4627 8778 Da5f98c12391 05)
The text provides details about a medication called Bumetanide Injection, USP, containing 0.25 mg of bumetanide per mL. The solution also includes other components such as sodium chloride, buffers, edetate disodium, and benzyl alcohol. The storage conditions, manufacturer information, and dosage guidance are all outlined. The container closure is specified to not contain natural rubber latex. The text further mentions the pH adjustment process and the inclusion of a preservative. Additionally, it advises on both the storage temperature range and precautions against light exposure.*
Image (D36fe175 34a6 4627 8778 Da5f98c12391 54 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
